SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-293022
Filing Date
2020-11-13
Accepted
2020-11-13 16:17:13
Documents
63
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d92623d10q.htm 10-Q 745737
2 EX-3.2 d92623dex32.htm EX-3.2 164219
3 EX-31.1 d92623dex311.htm EX-31.1 6168
4 EX-31.2 d92623dex312.htm EX-31.2 6135
5 EX-32.1 d92623dex321.htm EX-32.1 6521
  Complete submission text file 0001193125-20-293022.txt   4734976

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cfrx-20200930.xml EX-101.INS 1043914
7 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20200930.xsd EX-101.SCH 40449
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20200930_cal.xml EX-101.CAL 34308
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20200930_def.xml EX-101.DEF 152805
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20200930_lab.xml EX-101.LAB 344876
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20200930_pre.xml EX-101.PRE 267647
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 201311705
SIC: 2834 Pharmaceutical Preparations